Eric Lee, MD
Orthopedic Surgery · Orange, CANPI 1720075641
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,688 of the $13,209 with a category attached, or 88.5%. It is spread thinly across 44 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations.
Across 232 payments — averaging $56.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Smith+Nephew$2K
- Stryker$2K
- Johnson & Johnson$1K
- Pacira Therapeutics, Inc.$732
- Abanza Inc.$691
- plus $4K from 38 others
What the payments were for
- Travel & lodging$1,52112%
- Food & beverage$11,68888%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WasherCap Fixation System 10mm$691
- WasherCap Mini Fixation system 4.5mm$691
- MAKO$625
- Bioinductive Implant with Arthroscopic Delivery System - Medium$383
- ARISTA AH FLEXITIP$347
- STRATAFIX$238
- TRUESPAN ORTHOCORD$221
- PROFYLE$165
- HOFFMANN$149
- iTotal CR$145
- ARISTA$137
- SURGIFLO Hemostatic Matrix Family of Products$125
- GMK Sphere Revision System$121
- MPO Medial Pivot Knee$120
- AEQUALIS PERFORM REVERSED$115
- AEQUALIS ASCEND FLEX$115
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$115
- SIMPLICITI$115
- SURGIFLO Hemostatic Matrix$113
- Surgiphor$113
How this compares
$13,209 in reported general payments places this provider in the 85th percentile of 130 orthopedic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 57 | $1,943 |
| Meloxicam | 318 | $844 |
| Gabapentin | 29 | $242 |
| Ibuprofen | 19 | $222 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $169 |
| Naproxen | 12 | $154 |
| Diclofenac Sodium | 11 | $111 |
| Amoxicillin | 42 | $81 |
| Tramadol Hcl | 30 | $80 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $61 |
| Cyclobenzaprine Hcl | 18 | $52 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in Orange
- Ran SchwarzkopfOrange$2M
- Ayaz BivijiOrange$8K
- Marshall ChingOroville$17.8M
- Brian ChingOroville$1.4M
- Peter KurzweilLong Beach$494K
- Scott Hackerla Mesa$434K
- Richard NussbaumSherman Oaks$238K
- William KimTorrance$164K
- Peter BordenTorrance$111K
- Raymond FolmarIrvine$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.